Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Revance Therapeutics, Inc. (MM) RVNC NASDAQ Common Stock US7613301099
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00 +0.00% 20.30 20.60 19.95 20.50 20.30 20:00:00
more quote information »

Recent News

Date Time Source Heading
1/18/201716:43BWRevance Presents Clinical Data for RT002 Injectable at..
1/12/201706:04EDGARCurrent Report Filing (8-k)
1/11/201712:50EDGARAmended Statement of Ownership (sc 13g/a)
1/05/201716:36EDGARCurrent Report Filing (8-k)
1/05/201716:05BWRevance Provides Clinical Milestones and Financial Outlook..
1/03/201717:53EDGARStatement of Changes in Beneficial Ownership (4)
12/30/201618:39EDGARStatement of Changes in Beneficial Ownership (4)
12/12/201616:15EDGARCurrent Report Filing (8-k)
12/12/201616:05BWRevance Announces Positive 24-Week Duration of Effect in..
12/07/201608:00BWRevance Announces Initiation of Subject Dosing in the SAKURA..
11/17/201616:05BWRevance to Participate in the 28th Annual Piper Jaffray..
11/07/201616:05BWRevance to Participate in the Jefferies 2016 London..
11/04/201616:14EDGARQuarterly Report (10-q)
11/03/201616:18EDGARCurrent Report Filing (8-k)
11/03/201616:05BWRevance Releases Third Quarter 2016 Results
11/03/201608:00BWRevance Announces Initiation of Phase 2 Trial of RT002..
10/24/201616:05BWRevance Therapeutics to Release Third Quarter 2016 Financial..
8/30/201616:05BWRevance to Participate in the 2016 Wells Fargo Securities..
8/05/201616:11EDGARQuarterly Report (10-q)
8/04/201616:43EDGARCurrent Report Filing (8-k)
8/04/201616:05BWRevance Releases Second Quarter 2016 Results
7/25/201610:46BWShareholder Alert: Sohmer Law Firm Investigating Revance..
7/22/201609:07EDGARConfidential Treatment Order (ct Order)
7/21/201616:05BWRevance Therapeutics to Release Second Quarter 2016..
7/14/201616:02BWRevance Announces Completion of Pre-Phase 3 Meeting with FDA..
7/06/201619:54EDGARStatement of Changes in Beneficial Ownership (4)
7/06/201619:51EDGARInitial Statement of Beneficial Ownership (3)
7/05/201616:19EDGARCurrent Report Filing (8-k)
7/05/201608:00BWRevance Appoints Industry Leader Julian S. Gangolli to its..
6/15/201619:30EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201616:08EDGARCurrent Report Filing (8-k)
6/13/201616:01GLOBERevance Reports Results for RT001 Topical Phase 3 Trial for..
6/03/201617:08EDGARCurrent Report Filing (8-k)
6/02/201618:13GLOBERevance Expands Botulinum Toxin Assets by Acquiring..
5/31/201616:05GLOBERevance to Participate in Upcoming Investor Conferences
5/11/201618:43EDGARStatement of Changes in Beneficial Ownership (4)
5/10/201616:29EDGARQuarterly Report (10-q)
5/09/201619:20EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201619:17EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201619:15EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201619:13EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201619:11EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201619:09EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201619:08EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201617:40EDGARCurrent Report Filing (8-k)
5/09/201616:05GLOBERevance Releases First Quarter 2016 Results
4/28/201611:46GLOBERevance Therapeutics to Release First Quarter 2016 Financial..
4/13/201619:00EDGARStatement of Changes in Beneficial Ownership (4)
3/28/201606:01EDGARNotice of Effectiveness (effect)
3/25/201616:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
See more news about this stock »
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170124 05:14:18